Milbank LLP advised the lead arranger and agents in connection with the maturity extension of Elanco Animal Health Incorporated’s (NYSE: ELAN) (“Elanco”) $750 million revolving credit facility.
Elanco is a global leader in animal health, delivering products and services to prevent and treat disease in farm animals and pets.
The Milbank team was led by New York Global Leveraged Finance partners Lauren Hanrahan and Christopher Kwan, together with associates Julia Wennberg, Angelica Body-Lawson and Ian Tomesch, with assistance from Frankfurt partner Thomas Ingenhoven, special counsel Thomas Möller and associate Miriam Arimond, and London partner Sarbajeet Nag and associate Venandah Madanhi.
Milbank also previously advised on the approximately $5 billion financing of Elanco’s acquisition of Bayer AG’s animal health business.
